These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 26919511)
1. Pre-Treatment Serum C-Reactive Protein Level Is An Independent Risk Factor for Development of Nephrotoxicity in Patients Receiving High-Dose Vancomycin. He J; Mao EQ; Jing F; Jiang HT; Yang WH; Chen EZ Pharmacology; 2016; 97(5-6):294-300. PubMed ID: 26919511 [TBL] [Abstract][Full Text] [Related]
2. Incidence of nephrotoxicity and association with vancomycin use in intensive care unit patients with pneumonia: retrospective analysis of the IMPACT-HAP Database. Cano EL; Haque NZ; Welch VL; Cely CM; Peyrani P; Scerpella EG; Ford KD; Zervos MJ; Ramirez JA; Kett DH; Clin Ther; 2012 Jan; 34(1):149-57. PubMed ID: 22284995 [TBL] [Abstract][Full Text] [Related]
3. High-dose intravenous vancomycin therapy and the risk of nephrotoxicity. Rostas SE; Kubiak DW; Calderwood MS Clin Ther; 2014 Jul; 36(7):1098-101. PubMed ID: 24931573 [TBL] [Abstract][Full Text] [Related]
4. Comparison of the incidence of vancomycin-induced nephrotoxicity in hospitalized patients with and without concomitant piperacillin-tazobactam. Burgess LD; Drew RH Pharmacotherapy; 2014 Jul; 34(7):670-6. PubMed ID: 24855041 [TBL] [Abstract][Full Text] [Related]
5. Assessment of initial serum vancomycin trough concentrations and their association with initial empirical weight-based vancomycin dosing and development of nephrotoxicity in children: a multicenter retrospective study. Matson KL; Shaffer CL; Beck GL; Simonsen KA Pharmacotherapy; 2015 Mar; 35(3):337-43. PubMed ID: 25756622 [TBL] [Abstract][Full Text] [Related]
7. Nephrotoxicity in patients with vancomycin trough concentrations of 15-20 μg/ml in a pediatric intensive care unit. Cies JJ; Shankar V Pharmacotherapy; 2013 Apr; 33(4):392-400. PubMed ID: 23471688 [TBL] [Abstract][Full Text] [Related]
8. Incidence and predictors of vancomycin-associated nephrotoxicity. Moh'd H; Kheir F; Kong L; Du P; Farag H; Mohamad A; Zurlo JJ South Med J; 2014 Jun; 107(6):383-8. PubMed ID: 24945176 [TBL] [Abstract][Full Text] [Related]
9. Retrospective review of vancomycin-induced nephrotoxicity in patients with leukemia. Fullmer A; McCue D; Feng C J Oncol Pharm Pract; 2014 Dec; 20(6):403-8. PubMed ID: 24177356 [TBL] [Abstract][Full Text] [Related]
10. Trough concentration over 12.1 mg/L is a major risk factor of vancomycin-related nephrotoxicity in patients with therapeutic drug monitoring. Han HK; An H; Shin KH; Shin D; Lee SH; Kim JH; Cho SH; Kang HR; Jang IJ; Yu KS; Lim KS Ther Drug Monit; 2014 Oct; 36(5):606-11. PubMed ID: 24577126 [TBL] [Abstract][Full Text] [Related]
11. Vancomycin-associated nephrotoxicity in adult medicine patients: incidence, outcomes, and risk factors. Meaney CJ; Hynicka LM; Tsoukleris MG Pharmacotherapy; 2014 Jul; 34(7):653-61. PubMed ID: 24700598 [TBL] [Abstract][Full Text] [Related]
12. The Relationship of nephrotoxicity to vancomycin trough serum concentrations in a veteran's population: a retrospective analysis. Horey A; Mergenhagen KA; Mattappallil A Ann Pharmacother; 2012 Nov; 46(11):1477-83. PubMed ID: 23073306 [TBL] [Abstract][Full Text] [Related]
13. Pharmacodynamic Characteristics of Nephrotoxicity Associated With Vancomycin Use in Children. Le J; Ny P; Capparelli E; Lane J; Ngu B; Muus R; Romanowski G; Vo T; Bradley J J Pediatric Infect Dis Soc; 2015 Dec; 4(4):e109-16. PubMed ID: 26582878 [TBL] [Abstract][Full Text] [Related]
14. [Glycopeptides and the newborn infant's kidney]. Fanos V; Benini D; Vinco S; Pizzini C; Khoory BJ Pediatr Med Chir; 1997; 19(4):259-62. PubMed ID: 9508651 [TBL] [Abstract][Full Text] [Related]
15. Clinical outcomes and nephrotoxicity associated with vancomycin trough concentrations during treatment of deep-seated infections. Hermsen ED; Hanson M; Sankaranarayanan J; Stoner JA; Florescu MC; Rupp ME Expert Opin Drug Saf; 2010 Jan; 9(1):9-14. PubMed ID: 20021290 [TBL] [Abstract][Full Text] [Related]
17. Usefulness of a decision tree model for the analysis of adverse drug reactions: Evaluation of a risk prediction model of vancomycin-associated nephrotoxicity constructed using a data mining procedure. Imai S; Yamada T; Kasashi K; Kobayashi M; Iseki K J Eval Clin Pract; 2017 Dec; 23(6):1240-1246. PubMed ID: 28544476 [TBL] [Abstract][Full Text] [Related]
19. Intravenous Vancomycin Associated With the Development of Nephrotoxicity in Patients With Class III Obesity. Choi YC; Saw S; Soliman D; Bingham AL; Pontiggia L; Hunter K; Chuang L; Siemianowski LA; Ereshefsky B; Hollands JM Ann Pharmacother; 2017 Nov; 51(11):937-944. PubMed ID: 28709394 [TBL] [Abstract][Full Text] [Related]
20. Vancomycin-associated nephrotoxicity in the critically ill: a retrospective multivariate regression analysis*. Hanrahan TP; Harlow G; Hutchinson J; Dulhunty JM; Lipman J; Whitehouse T; Roberts JA Crit Care Med; 2014 Dec; 42(12):2527-36. PubMed ID: 25083977 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]